发明名称 INDOLE-2-CARBOXYLIC ACID DERIVATIVE
摘要 <p>PROBLEM TO BE SOLVED: To obtain the subject new compound that has little harmful side effect and high in-vivo activity, and is useful an excellent selective antagonist for glycine binding site of N-methyl-D-aspartic acid receptor. SOLUTION: This new compound is an indole-2-carboxylic acid derivative of formula I (X<1> , X<2> are independently H, an alkyl, halogen, cyano, etc.; R<1> is H, a carboxyl-protective group; R<2> is H or an alkyl; A is an acidic residue or group capable of being converted into an acid residue in vivo; E is a basic residue or group capable of being converted into a base residue in vivo; J is dimethylene or vinylene; Y is a single bond, alkylene etc.; Z is a single bond, or alkylnen) or its pharmacologically permissible salt, e.g. a compound of formula II. The compound of formula I is obtained, for example, by condensing a compound of formula III with a compound of formula IV [E<0> is a group of NHL<1> (L<1> is an amino acid, etc.); A<0> is a protected carboxyl[ followed by deprotection.</p>
申请公布号 JPH0940645(A) 申请公布日期 1997.02.10
申请号 JP19950212422 申请日期 1995.07.28
申请人 SUMITOMO PHARMACEUT CO LTD 发明人 NAGATA TATSU;AE NOBUYUKI
分类号 A61K31/40;A61K31/403;A61K31/404;A61P25/00;A61P25/08;A61P25/28;A61P43/00;C07D209/42;(IPC1-7):C07D209/42 主分类号 A61K31/40
代理机构 代理人
主权项
地址